37
Participants
Start Date
December 31, 1999
Primary Completion Date
May 31, 2003
Study Completion Date
March 31, 2010
1/10 NA/EE
Hormone replacement therapy with 1 mg norethindrone/10 mcg thinyl estradiol (1/10 NA/EE)
Placebo
1 mg placebo
Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740, Los Angeles
Parke-Davis
INDUSTRY
University of Pittsburgh
OTHER
University of Florida
OTHER
Allegheny University
UNKNOWN
University of Alabama at Birmingham
OTHER
Johns Hopkins University
OTHER
Cedars-Sinai Medical Center
OTHER